REAUTHORIZATION; REPORTING REQUIREMENTS.

SEC. 304. REAUTHORIZATION; REPORTING REQUIREMENTS. Section 744C of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 379j–43) is amended—(1) in subsection (a)—(A) by striking “2013” and inserting “2018”; and(B) by striking “Generic Drug User Fee Amendments of 2012” and inserting “Generic Drug User Fee Amendments of 2017”;(2) in subsection (b), by striking “2013” and inserting “2018”; and(3) in subsection (d), by striking “2017” each place it appears and inserting “2022”.